Life Spine announced successful completion of initial cases with the PLATEAU®-Ti Spacer, a titanium interbody system featuring OSSEO-LOC™ surface treatment to support potential bone growth.
Osseon has increased its independent distribution network by 26% since January 2016, and is on track to expand its vertebral augmentation line with three new VCF products in the pipeline.
Pre-clinical study results demonstrated that BONESUPPORT’s CERAMENT™, loaded with rhBMP-2 + zoledronic acid in very low doses, was able to quantitatively/qualitatively generate a high amount of mineralized bone volume.